Skip to main navigation Skip to search Skip to main content

Baricitinib in the treatment of adults with pyoderma gangrenosum: An open-label pilot trial

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)1684-1687.e6
JournalJournal of Investigative Dermatology
Volume146
Issue number6
DOIs
StatePublished - Jun 1 2026

Keywords

  • Dermatologic treatments
  • Jak inhibitor
  • Open-label study
  • Pyoderma gangrenosum
  • Ulcer

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this